Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma. Recommendation based on IMROZ phase 3 study demonstrating Sarclis ...
(NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery ... Our clinical programs are advancing with the ongoing Phase 2 study in second-line and later-stage gastric cancer ...
Initial results for odronextamab in first-line follicular lymphoma showcase compelling monotherapy potential and progress in the confirmatory trial Additional oral presentations explore odronextamab ...
New York Gov. Kathy Hochul has taken a step to revive congestion pricing before President-elect Donald Trump, who opposes the extra toll, takes office.